LinusBio Alternatives & Competitors
12 companies similar to LinusBio — Precision Exposome Medicine
Companies similar to LinusBio
NOBO Medicine
Precision Medicine in Oncology and Beyond
Voyager Therapeutics, Inc.
Leveraging genetics to treat neurological diseases
Multiomic Health
AI-Enabled Precision Medicine for Cardiovascular Renal Metabolic (CRM) Disease
Rival Readout
Competing with LinusBio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ikena Oncology (Merged with ImageneBio)
Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for mo...
Celsius Therapeutics
On a quest to leverage the power of single cell genomics to discover novel drug targets an...
Celadon Pharmaceuticals
UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannab...
Brainify.AI
AI biomarker platform for a novel treatment developed for depression. Part of J&J Jlabs an...
ProMIS™ Neurosciences, Inc.
Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Pa...
Anatolia Geneworks
Molecular Diagnostics Solutions
Novigenix SA
Leader in Immuno-Transcriptomic Precision Medicine solutions
PrecisionLife
AI-driven precision medicine for complex, chronic diseases. Creating better diagnostics &...
About LinusBio
LinusBio, founded in 2020, is a pioneering company operating at the forefront of Precision Exposome Medicine. Revolving around breakthrough science, the company focuses on patient-centric solutions within the biotechnology, health care, and pharmaceutical industries. Its innovative program pipeline is actively advancin...
Precision exposome biomarker development, Early diagnosis technology, AI-powered data analysis, Non-invasive diagnostic tests
Healthcare providers, Families of children with developmental disorders, Biotechnology researchers, Clinical experts, Pharmaceutical companies
Precision Exposome Medicine, Biomarkers, Target Discovery, CNS Disorders, Autism Spectrum Disorder, Amyotrophic Lateral Sclerosis, Inflammatory Bowel Disease, Renal Disease, Oncology, Genomic Diseases, Genomic Sequencing Analysis, Technology Platform, Precision Medicine, Patient-Centric Healthcare, Breakthrough Science
B2B, D2C, B2D
Product Sales, Service Fee, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around LinusBio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at LinusBio on 4 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.